Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Molina Healthcare jumps as investors focus on contract wins and growth outlook

None

Molina Healthcare (MOH) is up 7.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a mix of contract momentum and renewed confidence in Molina’s earnings path rather than a single fresh headline today. Investors seem to be reacting to the company’s recent Illinois Medicaid contract win, its reaffirmed 2026 outlook and long-term growth targets, and a new analyst initiation that highlighted near-term earnings visibility.

Details:

  • Molina said on June 10 that Illinois intends to award its subsidiary a HealthChoice Illinois Medicaid managed care contract, with a planned January 1, 2027 start and a term of four-and-a-half years plus extension options.
  • At its Investor Day, Molina reaffirmed 2026 guidance for at least $5.00 in adjusted EPS and outlined a 2027 revenue outlook of about $48 billion, supported by embedded revenue from contracts already won.
  • The same presentation also pointed to a longer-term target of roughly $64 billion in premium revenue by 2029 and adjusted EPS of about $25 if medical cost trends cooperate, reinforcing a margin-recovery story.
  • A June 23 analyst initiation set a $216 price target and emphasized earnings visibility through 2027, helped by contract wins in Illinois, Texas, and Georgia, which may have supported buying interest as the stock pushed higher.
  • Sources:

    Molina Healthcare, Investing.com, Stock Analysis

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $MOH Insider Trading Activity

    MOH Insider Trades

    $MOH insiders have traded $MOH stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $MOH stock by insiders over the last 6 months:

    • JEFF D. BARLOW (Chief Legal Officer) sold 17,811 shares for an estimated $3,314,983
    • MAURICE HEBERT (Chief Accounting Officer) sold 600 shares for an estimated $114,930
    • RICHARD C ZORETIC purchased 800 shares for an estimated $100,128
    • RONNA ROMNEY sold 506 shares for an estimated $74,341

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    $MOH Hedge Fund Activity

    We have seen 318 institutional investors add shares of $MOH stock to their portfolio, and 437 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $MOH Analyst Ratings

    Wall Street analysts have issued reports on $MOH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Wells Fargo issued a "Overweight" rating on 01/07/2026
    • Barclays issued a "Underweight" rating on 01/05/2026

    To track analyst ratings and price targets for $MOH, check out Quiver Quantitative's $MOH forecast page.

    $MOH Price Targets

    Multiple analysts have issued price targets for $MOH recently. We have seen 12 analysts offer price targets for $MOH in the last 6 months, with a median target of $185.5.

    Here are some recent targets:

    • Ben Hendrix from RBC Capital set a target price of $216.0 on 06/23/2026
    • John Stansel from JP Morgan set a target price of $191.0 on 06/08/2026
    • Erin Wright from Morgan Stanley set a target price of $167.0 on 06/04/2026
    • Andrew Mok from Barclays set a target price of $199.0 on 05/26/2026
    • A.J. Rice from UBS set a target price of $202.0 on 05/22/2026
    • Michael Ha from Baird set a target price of $163.0 on 05/11/2026
    • Sarah James from Cantor Fitzgerald set a target price of $209.0 on 05/11/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles